Cat #: BLP-NT103
Type: Synthetic peptide
Form: Lyophilized powder
A Blocking peptide for Anti-SLC7A2 (extracellular) Antibody (#ANT-103). Intended to be used as a negative control.
For research purposes only, not for human use
- Western blot analysis of Human THP-1 acute monocytic leukemia cells (lanes 1 and 6), mouse WEHI-231 B-cell lymphoma cells (lanes 2 and 7), rat RBL basophilic leukemia cells lysates (lanes 3 and 8), rat heart (lanes 4 and 9) and rat lung membranes (lanes 5 and 10):
- Expression of SLC7A2 (CAT-2) in mouse hippocampusImmunohistochemical staining of perfusion-fixed frozen mouse brain sections with Anti-SLC7A2 (extracellular) Antibody (#ANT-103), (1:300), followed by goat anti-rabbit-AlexaFluor-488. A. Staining in the hippocampal dentate gyrus region, showed SLC7A2 immunoreactivity (green) in neuronal profiles in the granule layer (G, vertical arrows) and in the hilus (H, horizontal arrows). B. Pre-incubation of the antibody with SLC7A2 (extracellular) Blocking Peptide (BLP-NT103), suppressed staining. Cell nuclei are stained with DAPI (blue).
- (C)KTYFKMNYTGLAE, corresponding to amino acid residues 151-163 of rat SLC7A2 (Accession B5D5N9).
Peptide Confirmation Confirmed by amino acid analysis and mass spectrometry.
Storage Before Reconstitution Lyophilized powder can be stored intact at room temperature for two weeks. For longer periods, it should be stored at -20°C.
Reconstitution 100 µl double distilled water (DDW).
Storage After Reconstitution -20°C.
Antigen Preadsorption Control 1 µg peptide per 1 µg antibody.
Standard Quality Control Of Each Lot Western blot analysis.
Shipping and Ordering information